Glioblastoma: Defining Tumor Niches

Trends in Cancer

Volumn 1, Issue 4, 2015, Pages 252-265

  Hambardzumyan, Dolores ^a   Bergers, Gabriele ^b,c  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

astrocytes; cancer stem cells; GBM; macrophages; microglial cells; therapy; tumor microenvironment; tumor niches; tumor vasculature

Indexed keywords

BEVACIZUMAB; CEDIRANIB; GELATINASE B; TRANSFORMING GROWTH FACTOR BETA;

ANGIOGENESIS; ANTIANGIOGENIC THERAPY; BLOOD BRAIN BARRIER; CANCER STEM CELL; CANCER SURVIVAL; CANCER THERAPY; CELL FUNCTION; CELL HETEROGENEITY; CELL PROLIFERATION; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; DRUG TARGETING; FUNCTIONAL STATUS; GLIOBLASTOMA; HISTOPATHOLOGY; HUMAN; HYPOXIC CELL; IMMUNOSURVEILLANCE; MACROPHAGE; MAINTENANCE THERAPY; MICROGLIA; MOLECULAR BIOLOGY; PHASE 2 CLINICAL TRIAL (TOPIC); PHASE 3 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STEM CELL NICHE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR INVASION; TUMOR MICROENVIRONMENT; VASCULARIZATION;

EID: 84957810905     PISSN: 24058033     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trecan.2015.10.009     Document Type: Review

References (111)

1. R. Stupp, and et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma N. Engl. J. Med. 352 2005 987 996
2. C.W. Brennan, and et al. The somatic genomic landscape of glioblastoma Cell 155 2013 462 477
3. Cancer Genome Atlas Research Network Comprehensive genomic characterization defines human glioblastoma genes and core pathways Nature 455 2008 1061 1068
4. R.G. Verhaak, and et al. Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1 Cancer Cell 17 2010 98 110
5. M. Snuderl, and et al. Mosaic amplification of multiple receptor tyrosine kinase genes in glioblastoma Cancer Cell 20 2011 810 817
6. N.J. Szerlip, and et al. Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response Proc. Natl. Acad. Sci. U.S.A. 109 2012 3041 3046
7. A. Sottoriva, and et al. Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics Proc. Natl. Acad. Sci. U.S.A. 110 2013 4009 4014
8. A.P. Patel, and et al. Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma Science 344 2014 1396 1401
9. S.K. Singh, and et al. Identification of human brain tumour initiating cells Nature 432 2004 396 401
10. J.D. Lathia, and et al. Cancer stem cells in glioblastoma Genes Dev. 29 2015 1203 1217
11. C. Calabrese, and et al. A perivascular niche for brain tumor stem cells Cancer Cell 11 2007 69 82
12. S. Bao, and et al. Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor Cancer Res. 66 2006 7843 7848
13. H.F. Dvorak Tumors: wounds that do not heal - redux Cancer Immunol. Res. 3 2015 1 11
14. R. Du, and et al. HIF1alpha Induces the Recruitment of Bone Marrow-Derived Vascular Modulatory Cells to Regulate Tumor Angiogenesis and Invasion Cancer Cell 13 2008 206 220
15. G. Bergers Bone marrow-derived cells in GBM neovascularization E.G. Meir, CNS Cancer (Part 3) 2009 Springer 749 773
16. R. Wang, and et al. Glioblastoma stem-like cells give rise to tumour endothelium Nature 468 2010 829 833
17. Y. Soda, and et al. Transdifferentiation of glioblastoma cells into vascular endothelial cells Proc. Natl. Acad. Sci. U.S.A. 108 2011 4274 4280
18. L. Ricci-Vitiani, and et al. Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells Nature 468 2010 824 828
19. L. Cheng, and et al. Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth Cell 153 2013 139 152
20. A. Kulla, and et al. Analysis of the TP53 gene in laser-microdissected glioblastoma vasculature Acta Neuropathol. 105 2003 328 332
21. X.M. Liu, and et al. Clinical significance of vasculogenic mimicry in human gliomas J. Neurooncol. 105 2011 173 179
22. F.J. Rodriguez, and et al. Neoplastic cells are a rare component in human glioblastoma microvasculature Oncotarget 3 2012 98 106
23. N.J. Abbott Blood-brain barrier structure and function and the challenges for CNS drug delivery J. Inherit. Metab. Dis. 36 2013 437 449
24. G. Bergers, and S. Song The role of pericytes in blood-vessel formation and maintenance Neuro Oncol. 7 2005 452 464
25. X. Feng, and et al. Loss of CX3CR1 increases accumulation of inflammatory monocytes and promotes gliomagenesis Oncotarget 6 2015 15077 15094
26. J. Liang, and et al. Neutrophils promote the malignant glioma phenotype through S100A4 Clin. Cancer Res. 20 2014 187 198
27. G. Kohanbash, and H. Okada Myeloid-derived suppressor cells (MDSCs) in gliomas and glioma-development Immunol. Invest. 41 2012 658 679
28. A. Mantovani, and et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes Trends Immunol. 23 2002 549 555
29. B.C. Kennedy, and et al. Tumor-associated macrophages in glioma: friend or foe? J. Oncol. 2013 2013 486912
30. F. Szulzewsky, and et al. Glioma-associated mocroglia/macrophages display an expression profile different from M1 and M2 polarization and highly express Gpnmb and Spp1 PLoS ONE 10 2015 e0116644
31. J.R. Engler, and et al. Increased microglia/macrophage gene expression in a subset of adult and pediatric astrocytomas PLoS ONE 7 2012 e43339
32. N.A. Charles, and et al. The brain tumor microenvironment Glia 60 2012 502 514
33. F. Ginhoux, and et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages Science 330 2010 841 845
34. B. Ajami, and et al. Local self-renewal can sustain CNS microglia maintenance and function throughout adult life Nat. Neurosci. 10 2007 1538 1543
35. M.R. Elmore, and et al. Colony-stimulating factor 1 receptor signaling is necessary for microglia viability, unmasking a microglia progenitor cell in the adult brain Neuron 82 2014 380 397
36. Hambardzumyan, D. et al. The role of microglia/macro-phages in glioma maintenance and progression. Nat. Neurosci. (in press)
37. F. Geissmann, and et al. Blood monocytes consist of two principal subsets with distinct migratory properties Immunity 19 2003 71 82
38. S. Yona, and et al. Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis Immunity 38 2013 79 91
39. N. Saederup, and et al. Selective chemokine receptor usage by central nervous system myeloid cells in CCR2-red fluorescent protein knock-in mice PLoS ONE 5 2010 e13693
40. R. Yamasaki, and et al. Differential roles of microglia and monocytes in the inflamed central nervous system J. Exp. Med. 211 2014 1533 1549
41. M. Mizutani, and et al. The fractalkine receptor but not CCR2 is present on microglia from embryonic development throughout adulthood J. Immunol. 188 2012 29 36
42. L. Yi, and et al. Glioma-initiating cells: a predominant role in microglia/macrophages tropism to glioma J. Neuroimmunol. 232 2011 75 82
43. X.Z. Ye, and et al. Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-beta1 signaling pathway J. Immunol. 189 2012 444 453
44. W. Zhou, and et al. Periostin secreted by glioblastoma stem cells recruits M2 tumour-associated macrophages and promotes malignant growth Nat. Cell Biol. 17 2015 170 182
45. A.M. Mikheev, and et al. Periostin is a novel therapeutic target that predicts and regulates glioma malignancy Neuro Oncol. 17 2015 372 382
46. D.J. Brat, and et al. Pseudopalisades in glioblastoma are hypoxic, express extracellular matrix proteases, and are formed by an actively migrating cell population Cancer Res. 64 2004 920 927
47. G.D. Yancopoulos, and et al. Vascular-specific growth factors and blood vessel formation Nature 407 2000 242 248
48. F.J. Wippold 2nd, and et al. Neuropathology for the neuroradiologist: palisades and pseudopalisades AJNR Am. J. Neuroradiol. 27 2006 2037 2041
49. D.J. Brat, and E.G. Van Meir Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma Lab. Invest. 84 2004 397 405
50. G.L. Semenza Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics Oncogene 29 2010 625 634
51. S. Seidel, and et al. A hypoxic niche regulates glioblastoma stem cells through hypoxia inducible factor 2 alpha Brain 133 2010 983 995
52. A. Soeda, and et al. Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha Oncogene 28 2009 3949 3959
53. E.E. Bar, and et al. Hypoxia increases the expression of stem-cell markers and promotes clonogenicity in glioblastoma neurospheres Am. J. Pathol. 177 2010 1491 1502
54. D. Zagzag, and et al. Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in glioblastoma: implications for angiogenesis and glioma cell invasion Lab. Invest. 86 2006 1221 1232
55. E.E. Bar Glioblastoma, cancer stem cells and hypoxia Brain Pathol. 21 2011 119 129
56. G.L. Semenza The hypoxic tumor microenvironment: a driving force for breast cancer progression Biochim. Biophys. Acta 2015 10.1016/j.bbamcr.2015.05.036 Published online June 14, 2015
57. D.J. Brat Glioblastoma: biology, genetics, and behavior Am. Soc. Clin. Oncol. Educ. Book 2012 2012 102 107
58. A. Filatova, and et al. The cancer stem cell niche(s): the crosstalk between glioma stem cells and their microenvironment Biochim. Biophys. Acta 1830 2013 2496 2508
59. J.M. Heddleston, and et al. Hypoxia-induced mixed-lineage leukemia 1 regulates glioma stem cell tumorigenic potential Cell Death Differ. 19 2012 428 439
60. Z. Li, and et al. Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells Cancer Cell 15 2009 501 513
61. B.Z. Qian, and J.W. Pollard Macrophage diversity enhances tumor progression and metastasis Cell 141 2010 39 51
62. A. Casazza, and et al. Impeding macrophage entry into hypoxic tumor areas by Sema3A/Nrp1 signaling blockade inhibits angiogenesis and restores antitumor immunity Cancer Cell 24 2013 695 709
63. B. Ruffell, and L.M. Coussens Macrophages and therapeutic resistance in cancer Cancer Cell 27 2015 462 472
64. L.B. Rivera, and G. Bergers Intertwined regulation of angiogenesis and immunity by myeloid cells Trends Immunol. 36 2015 240 249
65. V.A. Cuddapah, and et al. A neurocentric perspective on glioma invasion Nat. Rev. Neurosci. 15 2014 455 465
66. M. Westphal, and K. Lamszus The neurobiology of gliomas: from cell biology to the development of therapeutic approaches Nat. Rev. Neurosci. 12 2011 495 508
67. S.S. Lakka, and et al. Proteases and glioma angiogenesis Brain Pathol. 15 2005 327 341
68. R. Du, and et al. Matrix metalloproteinase-2 regulates vascular patterning and growth affecting tumor cell survival and invasion in GBM Neuro Oncol. 10 2008 254 264
69. M. Paez-Ribes, and et al. Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis Cancer Cell 15 2009 220 231
70. J.L. Rubenstein, and et al. Anti-VEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption Neoplasia 2 2000 306 314
71. C. Eckerich, and et al. Hypoxia can induce c-Met expression in glioma cells and enhance SF/HGF-induced cell migration Int. J. Cancer 121 2007 276 283
72. S.D. Rose, and M.K. Aghi Mechanisms of evasion to antiangiogenic therapy in glioblastoma Clin. Neurosurg. 57 2010 123 128
73. F.M. Iwamoto, and et al. Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma Neurology 73 2009 1200 1206
74. K.V. Lu, and et al. VEGF inhibits tumor cell invasion and mesenchymal transition through a MET/VEGFR2 complex Cancer Cell 22 2012 21 35
75. M. Luo, and et al. Epithelial-mesenchymal plasticity of breast cancer stem cells: implications for metastasis and therapeutic resistance Curr. Pharm. Des. 21 2015 1301 1310
76. C. Scheel, and R.A. Weinberg Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links Semin. Cancer Biol. 22 2012 396 403
77. T.M. Mathiisen, and et al. The perivascular astroglial sheath provides a complete covering of the brain microvessels: an electron microscopic 3D reconstruction Glia 58 2010 1094 1103
78. S. Watkins, and et al. Disruption of astrocyte-vascular coupling and the blood-brain barrier by invading glioma cells Nat. Commun. 5 2014 4196
79. L.A. Edwards, and et al. Effect of brain- and tumor-derived connective tissue growth factor on glioma invasion J. Natl. Cancer Inst. 103 2011 1162 1178
80. O.J. Becher, and et al. Gli activity correlates with tumor grade in platelet-derived growth factor-induced gliomas Cancer Res. 68 2008 2241 2249
81. V. Clement, and et al. HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity Curr. Biol. 17 2007 165 172
82. H. Kettenmann, and et al. Microglia: new roles for the synaptic stripper Neuron 77 2013 10 18
83. M. Sielska, and et al. Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response J. Pathol. 230 2013 310 321
84. E.Y. Lin, and et al. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy J. Exp. Med. 193 2001 727 740
85. S.J. Coniglio, and et al. Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling Mol. Med. 18 2012 519 527
86. S. Sarkar, and et al. Therapeutic activation of macrophages and microglia to suppress brain tumor-initiating cells Nat. Neurosci. 17 2014 46 55
87. A. Wu, and et al. Glioma cancer stem cells induce immunosuppressive macrophages/microglia Neuro Oncol. 12 2010 1113 1125
88. A. Müller, and et al. Resident microglia, and not peripheral macrophages, are the main source of brain tumor mononuclear cells Int. J. Cancer 137 2014 278 288
89. H.S. Venkatesh, and et al. Neuronal activity promotes glioma growth through neuroligin-3 secretion Cell 161 2015 803 816
90. H. Sontheimer A role for glutamate in growth and invasion of primary brain tumors J. Neurochem. 105 2008 287 295
91. M.H. Cohen, and et al. FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiforme Oncologist 14 2009 1131 1138
92. P.S. LaViolette, and et al. Vascular change measured with independent component analysis of dynamic susceptibility contrast MRI predicts bevacizumab response in high-grade glioma Neuro Oncol. 15 2013 442 450
93. M.R. Gilbert, and et al. A randomized trial of bevacizumab for newly diagnosed glioblastoma N. Engl. J. Med. 370 2014 699 708
94. T. Sandmann, and et al. Patients with proneural glioblastoma may derive overall survival benefit from the addition of bevacizumab to first-line radiotherapy and temozolomide: retrospective analysis of the AVAglio trial J. Clin. Oncol. 33 2015 2735 2744
95. C. Lu-Emerson, and et al. Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma J. Clin. Oncol. 33 2015 1197 1213
96. L.B. Rivera, and G. Bergers Tumor angiogenesis, from foe to friend Science 349 2015 694 695
97. G. Bergers, and D. Hanahan Modes of resistance to anti-angiogenic therapy Nat. Rev. Cancer 8 2008 592 603
98. K.V. Lu, and G. Bergers Mechanisms of evasive resistance to anti-VEGF therapy in glioblastoma CNS Oncol. 2 2013 49 65
99. E.R. Gerstner, and et al. Infiltrative patterns of glioblastoma spread detected via diffusion MRI after treatment with cediranib Neuro Oncol. 12 2010 466 472
100. E.R. Gerstner, and et al. Diffusion magnetic resonance imaging detects pathologically confirmed, nonenhancing tumor progression in a patient with recurrent glioblastoma receiving bevacizumab J. Clin. Oncol. 28 2010 e91 e93
101. Y. Piao, and et al. Glioblastoma resistance to anti-VEGF therapy is associated with myeloid cell infiltration, stem cell accumulation, and a mesenchymal phenotype Neuro Oncol. 14 2012 1379 1392
102. L.B. Rivera, and et al. Intratumoral myeloid cells regulate responsiveness and resistance to antiangiogenic therapy Cell Rep. 11 2015 577 591
103. F. Shojaei, and N. Ferrara Role of the microenvironment in tumor growth and in refractoriness/resistance to anti-angiogenic therapies Drug Resist. Updat. 11 2008 219 230
104. L. Zhang, and et al. Stat3 inhibition activates tumor macrophages and abrogates glioma growth in mice Glia 57 2009 1458 1467
105. F. Hu, and et al. Glioma-associated microglial MMP9 expression is upregulated by TLR2 signaling and sensitive to minocycline Int. J. Cancer 135 2014 2569 2578
106. S.M. Pyonteck, and et al. CSF-1R inhibition alters macrophage polarization and blocks glioma progression Nat. Med. 19 2013 1264 1272
107. N. Butowski, and et al. Phase 2 study of orally administered CSF1R inhibitor PLX3397 in recurrent glioblastoma: an Ivy Foundation Early Phase Clinical Trials Consortium Neuro Oncol. 2015 10.1093/neuonc/nov245 Published online October 8, 2015
108. S.J. Kim, and et al. Macitentan, a dual endothelin receptor antagonist, in combination with temozolomide leads to glioblastoma regression and long-term survival in mice Clin. Cancer Res. 21 2015 4630 4641
109. P.C. Nowell Mechanisms of tumor progression Cancer Res. 46 1986 2203 2207
110. M.R. Stratton, and et al. The cancer genome Nature 458 2009 719 724
111. R. Daneman, and et al. Pericytes are required for blood-brain barrier integrity during embryogenesis Nature 468 2010 562 566